3131 - 3140 of 9036 Results
Title
Year
-
OPENTitle: PFTK1 kinase regulates axogenesis during development via RhoA activationJournal Name: BMC BiologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page: 240End Page: 240Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12915-023-01732-wBest OA location URL: https://bmcbiol.biomedcentral.com/counter/pdf/10.1186/s12915-023-01732-wCitation Count: 2
-
OPENTitle: Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer’s disease-associated biomarkers alterations among de novo Parkinson’s disease patients: a prospective cohort studyJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page: 167End Page: 167Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-023-02843-5Best OA location URL: https://jneuroinflammation.biomedcentral.com/counter/pdf/10.1186/s12974-023-02843-5Citation Count: 56
-
OPENTitle: Locus specific endogenous retroviral expression associated with Alzheimer’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page: 1186470End Page: 1186470Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2023.1186470Best OA location URL: https://doi.org/10.3389/fnagi.2023.1186470Citation Count: 18
-
OPENTitle: Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson’s disease patients and healthy controlsJournal Name: BMC MedicinePublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page: 272End Page: 272Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12916-023-02994-5Best OA location URL: https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-023-02994-5Citation Count: 8
-
OPENTitle: Antihypertensive drugs may not delay the symptom progression of Parkinson’s disease: A 2-year follow-up studyJournal Name: HeliyonPublisher: Elsevier BVVol: 9Issue #: 8Start Page: e18538End Page: e18538Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.heliyon.2023.e18538Best OA location URL: http://www.cell.com/article/S2405844023057468/pdfCitation Count: 0
-
OPENTitle: DORIS: A diffusion MRI-based 10 tissue class deep learning segmentation algorithm tailored to improve anatomically-constrained tractographyJournal Name: Frontiers in NeuroimagingPublisher: Frontiers Media SAVol: 1Issue #:Start Page: 917806End Page: 917806Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnimg.2022.917806Best OA location URL: https://doi.org/10.3389/fnimg.2022.917806Citation Count: 12
-
OPENTitle: Characterization of Early Stage Parkinson's Disease From Resting-State fMRI Data Using a Long Short-Term Memory NetworkJournal Name: Frontiers in NeuroimagingPublisher: Frontiers Media SAVol: 1Issue #:Start Page: 952084End Page: 952084Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnimg.2022.952084Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnimg.2022.952084/pdfCitation Count: 29
-
OPENTitle: Brain‐Targeted Liposomes Loaded with Monoclonal Antibodies Reduce Alpha‐Synuclein Aggregation and Improve Behavioral Symptoms in Parkinson's DiseaseJournal Name: Advanced MaterialsPublisher: WileyVol: 35Issue #: 51Start Page: e2304654End Page: e2304654Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/adma.202304654Best OA location URL: https://doi.org/10.1002/adma.202304654Citation Count: 83
-
OPENTitle: PARK15 / FBXO7 is dispensable for PINK1 /Parkin mitophagy in iNeurons and HeLa cell systemsJournal Name: EMBO ReportsPublisher: Springer Science and Business Media LLCVol: 24Issue #: 8Start Page: e56399End Page: e56399Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embr.202256399Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embr.202256399Citation Count: 34
-
OPENTitle: The effects of AQP4 rs162009 on resting‐state brain activity in Parkinson's diseaseJournal Name: CNS Neuroscience & TherapeuticsPublisher: WileyVol: 29Issue #: 9Start Page: 2645End Page: 2655Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/cns.14208Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cns.14208Citation Count: 17